Valuation Pentixapharm Holding AG OTC Markets

Stocks

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

08-06	Pentixapharm Holding AG Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-06	Pentixapharm Holding AG and Pentixapharm AG Announce Executive Changes	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	73.15	36.73	46.1	-	-
Change	-	-49.79%	25.51%	-	-
Enterprise Value (EV) ¹	73.15	36.73	38.8	58.4	78.5
Change	-	-49.79%	5.63%	50.52%	34.42%
P/E	-	-	-3.05x	-2.86x	-2.82x
PBR	-	-	-	-	-
PEG	-	-	-	-0.44x	-1.86x
Capitalization / Revenue	620x	395x	-	-	-
EV / Revenue	620x	395x	-	-	-
EV / EBITDA	-	-	-1.87x	-2.64x	-3.46x
EV / EBIT	-4.31x	-1.85x	-2.75x	-2.36x	-4.22x
EV / FCF	-	-	-3.68x	-2.73x	-5.13x
FCF Yield	-	-	-27.2%	-36.6%	-19.5%
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-	-	-0.62	-0.66	-0.67
Distribution rate	-	-	-	-	-
Net sales ¹	0.118	0.093	-	-	-
EBITDA ¹	-	-	-20.8	-22.1	-22.7
EBIT ¹	-16.97	-19.86	-14.1	-24.7	-18.6
Net income ¹	-	-	-22.3	-23.5	-24.1
Net Debt ¹	-	-	-7.3	12.3	32.4
Reference price ²	2.950	1.482	1.890	1.890	1.890
Nbr of stocks (in thousands)	24,795	24,783	24,783	-	-
Announcement Date	4/15/25	3/25/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.6x	12.18x	24.75x	0.59%	1,053B
JOHNSON & JOHNSON	30.11x	6.7x	18.74x	1.98%	652B
ABBVIE INC.	33.53x	7.84x	16.21x	2.59%	468B
ROCHE HOLDING AG	19.76x	4.82x	11.93x	2.75%	351B
NOVARTIS AG	20.25x	5.27x	13.08x	3.03%	273B
ASTRAZENECA PLC	20.9x	4.34x	12.34x	2.04%	254B
AMGEN INC.	25.65x	6.7x	11.94x	2.48%	220B
GILEAD SCIENCES, INC.	-45.27x	6.59x	25.75x	2.2%	186B
NOVO NORDISK A/S	11.33x	4.13x	8.58x	4.44%	170B
Average	16.65x	6.51x	15.92x	2.46%	403.04B
Weighted average by Cap.	24.17x	7.86x	18.10x	1.97%